By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043



Company News
Collegium (COLL) Announces Publication Of Data On Oral Abuse Potential Of Xtampza ER 9/29/2016 11:46:23 AM
Collegium (COLL) Release: Review Of Xtampza ER Published In JAMA 9/9/2016 7:27:44 AM
Collegium (COLL) To Present At The Biocentury Newsmakers Conference 9/8/2016 8:25:50 AM
Collegium (COLL) Announces Scientific Presentations At PAINWeek 2016 Meeting 9/1/2016 8:16:58 AM
Collegium (COLL) To Host Conference Call To Discuss Second Quarter 2016 Financial Results And Provide Corporate Update 8/5/2016 10:10:59 AM
Collegium (COLL) Receives European Patent Allowance Covering Xtampza┬« ER 8/1/2016 8:37:03 AM
Collegium (COLL) Announces Commercial Launch Of Xtampza ER 6/20/2016 8:10:44 AM
BioDelivery (BDSI) And Collegium (COLL) Announce The Signing Of A Licensing Agreement For ONSOLIS In The U.S. 5/12/2016 6:46:39 AM
Collegium (COLL) Announces FDA Acceptance Of IND Application For Abuse-Deterrent, Hydrocodone Deterx 1/21/2016 7:41:36 AM
Collegium (COLL) Delays Launch of OxyContin Variation Xtampza 12/30/2015 6:30:34 AM